Crossing the next frontier to give you a fair chance to fight. We develop next-generation immunotherapies presenting a synergistic combination potentialwith standard-of-care treatments, to give patients a fair chance to fight immune-mediatedchronic diseases and cancer.We are committed to developing novel medicines with an unprecedented benefit-risk ratio to allow greater access to treatments. Giving patients a fair chance to fight is why we seek out unexplored therapeutic solutions, and why we founded Exeliom Biosciences. We source our drug candidates by studying and analyzing real-life observational human clinical trial data, in a non-systematic manner and without a priori. This pioneering translational approach, "human discovery first", is what makes us and our programs so special. ‍Check out our website for more info: https://www.exeliombio.com/My role includes:-overseeing operations across all functional areas in the company: process development, manufacturing, quality, regulatory, clinical, legal. -managing collaborations with academic and industrial partners -building the company development plan along with the CEO to suit time and budget constraints -reporting activities to investors -seeking more funding opportunities

Agoranov fosters the creation of innovative startups by providing a professional and friendly environment and by facilitating their access to expertise, tools and infrastructure crucial to success and rapid growth.-Managed the selection process of projects applying to Agoranov along with the team -Worked with 4 start-ups on their business issues: business plan, licensing strategy, pitch deck

=> EXIT: acquired by SnapchatNextmind is Paris-based company developing the next generation of brain computer interfaces.-Conducted the seed round of fundraising along with the founder-Applied for the i-LAB and Concours d'Innovation start-up competitions of Bpifrance-Developed the go-to-market strategy (communication and branding, user tests…)

MSc in biomedical engineering and technology transfer at Institut Imagine, a leading R&D center dedicated to innovative therapies for genetic diseases.-Collaborated with researchers and clinicians in a cross-disciplinary team to build the go-to-market strategy of an innovative treatment for osteogenesis imperfecta on the basis of a proof of concept on murine models. Designed the business plan and presented it to investors and experts to validate the opportunity. -Worked with a Grenoble-based start-up spin-off from the CEA to build the development strategy of applications of its innovative technology to the healthcare sector

=> EXIT: acquired by StaffbaseThe future of employee feedback survey. Employee engagement service based on anonymous and real-time feedback. -Implemented online and offline marketing: blogging, branding, participation in trade fairs in Hamburg, Zurich, Stuttgart and Paris. -Managed the French-speaking clients portfolio-Planned with the CEO the second funding round resulting in €2M raised-Worked part-time remotely in Paris for 10 months to generate leads and write online marketing content

C-level consulting firm focused on energy, construction, aeronautics and defense. -Conducted an in-depth market analysis for a project of securing global maritime container transport-Planned the entry of a leading French construction firm on the market of hospitals in 14 African countries -Wrote recommendations for the acquisition of a Kazakh target by a European energy leader

Consulting structure within HEC Paris, 18 students elected by the school, 150 studies a year, 800K€ turnover -Renewed partnerships with KPMG and Oliver Wyman -Managed human resources: holiday plan, recruitment and training process of the new team-Led board meetings on a weekly basis

-Led over 20 consulting projects with French leading firms (ERDF, Eiffage) as well as entrepreneurs (jewellery, digital platform for medicine students) -Managed customer relationships, recruited and managed HEC students-Trained new project managers by conducting studies in pairs-Prepared annual audit with the team